Tolkach, Alexey D.
23  Ergebnisse:
Personensuche X
?
 
?
 
?
 
?
 
?
6

MO856: Immunogenicity and Adverse Events After Vaccination ..:

Parshina, Ekaterina ; Tolkach, Alexey ; Ivanov, Andrey.
Nephrology Dialysis Transplantation.  37 (2022)  Supplement_3 - p. , 2022
 
?
7

MO836: Patients Receiving Haemodialysis Maintain Sars-Cov-2..:

Parshina, Ekaterina ; Tolkach, Alexey ; Ivanov, Andrey.
Nephrology Dialysis Transplantation.  37 (2022)  Supplement_3 - p. , 2022
 
?
 
?
 
?
10

MO812: Risk Factors of Long-Term Hypocalcemia After Parathy..:

Kislyy, Pavel ; Parshina, Ekaterina ; Zulkarnaev, Aleksei.
Nephrology Dialysis Transplantation.  37 (2022)  Supplement_3 - p. , 2022
 
?
11

P1428PERSISTENT HUNGRY BONE SYNDROME AND HYPOPARATHYROIDISM..:

Chernikov, Roman ; Tolkach, Alexey ; Kislyy, Pavel...
Nephrology Dialysis Transplantation.  35 (2020)  Supplement_3 - p. , 2020
 
?
12

PATIENTS RECEIVING HEMODIALYSIS DO NOT LOSE SARS-COV-2 ANTI..:

Parshina, Ekaterina ; Zulkarnaev, Alexey ; Tolkach, Alexey...
Parshina, E., Zulkarnaev, A., Tolkach, A., Ivanov, A. V., Kislyy, P., & Gaipov, A. (2022). Patients receiving hemodialysis do not lose SARS-CoV-2 antibodies more rapidly than non-renal controls: a prospective cohort study. Renal Failure, 44(1), 391–397. https://doi.org/10.1080/0886022x.2022.2042310.  , 2022
 
?
14

Patients receiving hemodialysis do not lose SARS-CoV-2 anti..:

Ekaterina Parshina ; Alexey Zulkarnaev ; Alexey Tolkach...
https://www.tandfonline.com/doi/10.1080/0886022X.2022.2042310.  , 2022
 
1-15